
ViiV Healthcare unveiled new data at the Conference on Retroviruses and Opportunistic Infections on next-generation long-acting HIV therapies.

ViiV Healthcare unveiled new data at the Conference on Retroviruses and Opportunistic Infections on next-generation long-acting HIV therapies.

An abstract presented at CROI 2026 found that continuous Medicaid coverage during the COVID-19 public health emergency was associated with decreased dependence on AIDS Drug Assistance Programs.

Zimbabwe has become one of the first countries in the world to launch a national lenacapavir program, introducing the twice-yearly injectable HIV prevention drug as part of its ongoing efforts to reduce new infections and end AIDS as a public health threat.

In this video interview, Joseph Kleiman, president of Buzz Health, says that patients should always “do their homework” to see if they are paying the lowest possible price for their prescription, whether that’s through TrumpRx or another website.

A conversation with Joseph Kleiman emphasizes price transparency, consumer research and the need for consistent pricing and drug availability.

A study of older women suggests that greater muscle strength lowers the risk of death, regardless of other factors like sedentary behavior.

Citing updated scientific evidence, the FDA has revised safety labels for six menopause hormone therapies, removing previous boxed warnings to better reflect current understanding of their risks and benefits for women in early menopause

Aetna Medicaid and the National Association of Community Health Centers have partnered to reduce high blood pressure rates among Medicaid members in select states by expanding community-based care.

A conversation with Gil Yosipovitch, M.D., explores why itch worsens at night, how it rivals chronic pain in quality-of-life impact, and why better assessment of nighttime itch and sleep disruption is urgently needed.

Florida’s planned AIDS Drug Assistance Program cuts could strip more than 16,000 people of life-saving HIV medications, a move Colleen Kelley, M.D., M.P.H., warns will increase illness, deaths and HIV transmission while sowing fear among already vulnerable patients.

TrumpRx launched as a government-branded, direct-to-consumer discount platform for select brand-name drugs, but critics argue its cash-only savings may be limited, potentially misleading, and less cost-effective over time than traditional insurance or other programs.

Adolescent and young women are far less likely than men to receive HIV prevention medication despite meeting clinical eligibility and facing substantial HIV risk.

Massachusetts leads SmileHub’s women’s health ranking, revealing cost barriers, safety gaps and state policies that shape care and outcomes.


A large Korean, population-based study of more than 2 million women suggests that patterns across a woman’s reproductive life may influence ovarian cancer risk, with some factors increasing risk and others appearing protective.

The award will involve patients with chronic disease and their families to inform clinical research, with an initial focus on diabetes.

A recent study found that older adults who received the shingles vaccine were biologically younger than those who didn’t, which suggests the vaccine may slow aspects of biological aging as well as prevent shingles.

Although Medicaid expansion has been linked to lower mortality, significant racial disparities persist.

More Americans are tracking and changing their sleep habits, but the growing cultural focus on sleep data is also increasing anxiety, with orthosomnia leaving many people awake at night.

Unrest is escalating in Minnesota after federal immigration officers killed two civilians including ICU nurse Alex Pretti, prompting more than 60 Minnesota CEOs and national nursing organizations to call for de-escalation, accountability and a transparent investigation of the incidents.

In this interview, Emma Kaplan-Lewis, M.D., clinical quality director for HIV, hepatitis and sexual health services at NYC Health + Hospitals, discusses the results of her latest case study on PrEP uptake and why it’s important to “celebrate success.”

In this interview, Danielly Fausto, Ph.D., physical education researcher at the Santa Catarina State University in Brazil, discusses the importance of midlife physical activity, how she’s come to terms with the initially "disappointing" results of her recent study and why it’s essential to keep talking about menopause.

Sleep deprivation of 21 hours or more significantly reduces cooperation and overall team performance, causing individuals to prioritize personal success over collective effectiveness while overestimating how well their team is functioning.

Gedatolisib is an investigational treatment for patients with HR+/HER2- PIK3CA wild-type advanced breast cancer

Self-administered HPV screening promises greater patient comfort and higher detection rates, though solutions for large-scale rollout and follow-up are still needed.

In this interview, Abbey Berenson, M.D., MMS, Ph.D., director for the Center of Interdisciplinary Research in Women's Health at the University of Texas Medical Branch, discusses the potential of self-swabbing for HPV screening to improve early detection of cervical cancer, particularly for underserved populations, while emphasizing the necessity of follow-up with healthcare providers.

A study using global health records reports that color-blind individuals face higher bladder cancer mortality, potentially due to delayed detection of blood in urine, while no similar survival difference is seen in colorectal cancer.

In 2024, U.S. health care spending rose to $5.3 trillion, driven by increased per capita use and demand for medical services as utilization rebounded following the COVID-19 pandemic.

A long-term UK Biobank analysis shows that while early or surgical menopause initially appears linked to higher diabetes rates, this association disappears after accounting for lifestyle and cardiovascular risk factors rather than menopause timing itself.

United States health care spending rose to $5.3 trillion in 2024, accounting for 18% of the economy, as strong post-pandemic demand and high insurance coverage continued to drive costs upward.